IBA Worldwide
IBA develops, manufactures and supports medical devices and software solutions for cancer treatment by proton beam therapy.
Launch date
Employees
Market cap
€392m
Enterprise valuation
€392m (Public information from Sep 2024)
Share price
€13.7 IBAB.BR
Ottignies-Louvain-la-Neuve Walloon Brabant (HQ)
Authorizing premium user...